Soleus Capital Management »

Theratechnologies shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Theratechnologies (THTX) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Theratechnologies

Tip: Access up to 7 years of quarterly data

All positions including Theratechnologies held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theratechnologies by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.8M 4.8M 1.62
2023-09-30 $5.0M 2.3M 2.15

More positions owned by Soleus Capital Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Rayzebio
Edap Tms S A Sponsored Adr (EDAP)
Organogenesis Hldgs (ORGO)
Humana (HUM)
Celcuity (CELC)
Iradimed (IRMD)
Essa Pharma Com New (EPIX)
SurModics (SRDX)
Hca Holdings (HCA)
Vaxcyte (PCVX)
Neuropace (NPCE)
Nuvalent Inc-a (NUVL)

View all positions for Soleus Capital Management

Top funds holding Theratechnologies

Soleus Capital Management
AIGH Capital Management
Nantahala Capital Management
Worth Venture Partners
Advisor Group Holdings
National Bank Of Canada /fi/
Stifel Financial
Sontag Advisory
Bank Of Montreal
Hamilton Capital Management
Summit Trail Advisors
Citadel Advisors
Beacon Pointe Advisors
Creative Financial Designs
Bare Financial Services

View all funds holding Theratechnologies